Auvelity Could Be the Best Rapid-acting Antidepressant For Major Depressive Disorder

By , in Health News on . Tagged width: , ,

In recent times, a lot of attention has been paid to the impacts and qualities of Auvelity. But what exactly is Auvelity, and what are the possibilities that it will replace Prozac as the most effective antidepressant medication for the treatment of severe depressive disorder? Continue reading to discover all of the relevant facts that you require.

Disclosure of the Effectiveness, Properties, and Adverse Effects of Auvelity

A new N-methyl-D-aspartate (NMDA) receptor antagonist with multifunctional efficacy, Auvelity (a proprietary formulation of dextromethorphan and bupropion), is recommended for the therapeutic management of major depressive disorder (MDD) in adults. Back in March of this year, the Food and Drug Administration (FDA) is the US actually recognized Auvelity as a breakthrough medicine for the treatment of MDD.

Additionally, the medicine has been given the fast-track designation for the treatment of treatment-resistant depression as well as agitation associated with AD. But how precisely does the Auvelity system function?

The inner workings of Auvelity’s action mechanism

It is not understood how exactly Auvelity works to treat major depressive disorder (MDD). Still, it is thought that the medication influences a number of distinct substances by acting on several receptors in the brain. Let’s start with its two primary components and analyze their operation from there.

We begin with dextromethorphan, which has a unique mode of action and is a not competitive NMDA receptor antagonist, also known as an ionotropic glutamate receptor modulator. Additionally, it acts as an agonist for the sigma-1 receptor.

The bupropion is the second component to consider. Because of this component’s capacity to prevent the absorption of both norepinephrine and dopamine, dextromethorphan is more readily available to the body.

Currently, Auvelity is safeguarded by one hundred patents that have been issued in the United States as well as other countries. These patents are valid until at least 2037 or 2040.

Are there any clinical trials on Auvelity?

Its efficacy was proven for the treatment of MDD in clinical research called GEMINI, which was controlled with a placebo. This was followed by confirmatory data, which included another clinical study called ASCEND, which matched Auvelity to bupropion hydrochloride sustained-release pills.

Adult patients who met the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnosis for major depressive disorder were included in the study’s findings. These patients were actually randomly assigned to receive either Auvelity or a placebo twice daily for a period of six weeks.

As measured by the variation in MADRS overall rating at week six, it was discovered that the antidepressant medication Auvelity was statistically and substantially more effective than the placebo in reducing the symptoms of depression. The MADRS serves as a scale that is graded by clinicians and is used to measure the degree to which depressive symptoms are present.

Patients diagnosed with MDD who participated in the ASCEND study were given one of two treatments: either Auvelity or bupropion hydrochloride sustained-release tablets 105mg twice per day for a period of six weeks.

Headache, dizziness, tiredness, diarrhea, trouble with sexual function, dry mouth, and a lot of sweat were identified as the most prevalent adverse effects experienced by individuals using Auvelity over the course of the clinical studies.

Tiesha loves to share her passion for everything that’s beautiful in this world. Apart from writing on her beauty blog and running her own beauty channel on Youtube, she also enjoys traveling and photography. Tiesha covers various stories on the website.